Ivecop 12 mg Tablets: Uses, Dosage & Safety Guide
Updated: Sep 17
Written by Elizabeth Chernoby in TheSkyMeds Editorial Standards
Medically reviewed by Jonathan Reed, Medical Content Reviewer on Mar 2 2026
Ivecop 12 mg is a prescription antiparasitic tablet containing ivermectin 12 mg and marketed in India by A. Menarini India. Ivecop 12 mg tablets may be prescribed for certain parasitic infections, but the correct use and dose depend on the parasite being treated and factors such as body weight. Ivermectin works against susceptible parasites by disrupting their nerve and muscle function, ultimately killing or disabling them. A 12 mg tablet is a fixed strength, but ivermectin treatment is frequently calculated in micrograms per kilogram of body weight, so one tablet is not automatically the correct dose for every person or infection.
Ivermectin is also not a general-purpose “deworming” medicine for every intestinal parasite. This guide explains Ivecop's uses, general dosing principles, side effects, precautions, and situations in which medical advice is particularly important.
What Is Ivecop 12 mg and What Is It Used For?
Ivecop 12 mg contains ivermectin, an antiparasitic medicine. Current Indian medicine listings identify each Ivecop 12 tablet as containing 12 mg ivermectin and list A. Menarini India as the marketer/manufacturer.
Ivermectin has established uses against certain parasitic infections. However, the precise approved indications can differ by country and product, so the prescribing information for the locally supplied medicine should guide its use.
Strongyloidiasis
Strongyloidiasis is caused by Strongyloides, a parasitic roundworm. Infection can cause abdominal symptoms, diarrhoea, skin rashes, or sometimes no noticeable symptoms at all.
The CDC clinical guidance for Strongyloides treatment identifies ivermectin as first-line therapy for acute and chronic strongyloidiasis.
Strongyloides infection deserves particular attention in people with weakened immune systems. Hyperinfection or disseminated disease can become extremely serious, especially in people receiving high-dose corticosteroids.
Scabies
Ivermectin can also be used in the treatment of scabies in some circumstances. Scabies is a skin infestation caused by the human itch mite and typically causes intense itching and a characteristic rash.
The CDC clinical guidance for scabies lists oral ivermectin as a treatment option for classic scabies, although it notes that oral ivermectin is not FDA-approved for this indication in the United States.
Scabies treatment involves more than taking medicine. Close contacts may need assessment or treatment, and clothing, bedding, and towels need appropriate cleaning to help prevent reinfestation and transmission.
Other parasitic infections
Ivermectin is used against some additional parasitic infections, but it should not be assumed to work against every worm or parasite. CDC guidance, for example, includes ivermectin as a treatment option for ascariasis, while recommendations differ for other soil-transmitted helminths.
This is why identifying the likely infection matters before treatment.
Examples of conditions for which oral ivermectin may be used
Condition | Role of ivermectin | Important consideration |
Strongyloidiasis | Established antiparasitic treatment | CDC lists ivermectin as first-line therapy |
Classic scabies | Oral treatment option | Treatment commonly requires repeat dosing; recommendations vary by jurisdiction |
Crusted scabies | Used with topical treatment | Requires more intensive treatment and medical supervision |
Ascariasis | Treatment option in CDC guidance | Dose is weight-based |
Other parasitic infections | May have a role in selected infections | Diagnosis and recommended regimen depend on the parasite |
The table describes ivermectin generally and should not be interpreted as confirmation that every indication is specifically approved for the Ivecop brand in India.
“Ivecop 12 mg” describes the strength of one tablet—not the correct dose for every infection. Ivermectin regimens can depend on body weight, the parasite being treated, whether repeat treatment is required, and individual safety considerations.
How Does Ivecop 12 mg Work Against Parasites?
Ivermectin interferes with important nerve and muscle functions in susceptible parasites. This causes paralysis and death of the parasite or prevents it from functioning normally, allowing the infection to be cleared.
Importantly, its activity is selective for particular parasites. Taking ivermectin simply because someone has itching, abdominal symptoms, or suspects “worms” is therefore not a reliable approach.
Different parasites can require entirely different medicines.
For example, treatment choices for common intestinal worms may include albendazole, mebendazole, pyrantel pamoate, or ivermectin depending on the particular infection. Scabies treatment may involve topical permethrin rather than—or in some circumstances alongside—oral ivermectin.
Diagnosis or an appropriate clinical assessment therefore comes before choosing an antiparasitic treatment.
What Is the Recommended Dosage of Ivecop 12 mg?
There is no single Ivecop 12 mg dosage that is correct for every person. Ivermectin dosing is commonly weight-based, and the appropriate regimen changes according to the infection being treated.
For example, CDC guidance for uncomplicated acute or chronic strongyloidiasis lists oral ivermectin at 200 micrograms per kilogram of body weight for 1–2 days.
For classic scabies, CDC clinical guidance describes two doses of oral ivermectin at 200 micrograms/kg per dose, taken 7–14 days apart. The CDC notes that this represents an off-label oral use in the United States.
These are disease-specific clinical recommendations for ivermectin—not instructions for self-treatment with Ivecop.
Examples showing why ivermectin dosing must be matched to the infection
Clinical situation | Example guidance | Key limitation |
Acute/chronic strongyloidiasis | 200 micrograms/kg orally for 1–2 days in CDC guidance | Dose is weight-based and requires an appropriate diagnosis |
Classic scabies | 200 micrograms/kg per dose, with two doses 7–14 days apart in CDC guidance | Oral ivermectin is off-label for scabies in the USA; local guidance may differ |
Crusted scabies | Multiple weight-based ivermectin doses plus topical treatment | Severe condition requiring clinician-directed therapy |
Severe/disseminated strongyloidiasis | More prolonged ivermectin treatment may be required | Potentially life-threatening condition requiring medical management |
The CDC ivermectin dosing recommendations for strongyloidiasis illustrate why a fixed 12 mg tablet should not be interpreted as a universal adult dose.
Should Ivecop be repeated after one dose?
That depends entirely on what is being treated.
For scabies, repeat ivermectin treatment is commonly recommended because the medicine has limited activity against mite eggs. CDC guidance therefore recommends a second oral dose for classic scabies when ivermectin is used.
Other parasitic infections can require a different schedule. Do not repeat Ivecop simply because symptoms remain after the first tablet; persistent symptoms can require reassessment rather than another unsupervised dose.
What Are the Side Effects of Ivecop 12 mg?
Like other medicines, ivermectin can cause side effects, although not everyone experiences them. Current Indian product information for Ivecop lists effects including dizziness, nausea, vomiting, and stomach discomfort.
Possible effects associated with ivermectin can vary depending on the infection being treated and the person's response to treatment.
Symptoms to watch for can include:
Dizziness
Nausea
Vomiting
Abdominal or stomach discomfort
Diarrhoea
Headache
Weakness or tiredness
Skin reactions
Some symptoms occurring after antiparasitic treatment may also result from the body's inflammatory response to dying parasites rather than simply a direct medicine side effect. The clinical context therefore matters.
Seek medical attention for severe or unusual symptoms, particularly significant swelling, difficulty breathing, severe rash, fainting, marked confusion, severe weakness, or other rapidly worsening symptoms.
Who Should Be Careful Before Taking Ivecop 12 mg?
Ivecop should be taken only after considering factors that may affect ivermectin's safety. This is particularly important during pregnancy, breastfeeding, in small children, and in people with certain parasitic coinfections.
Pregnancy and breastfeeding
Evidence for ivermectin use during pregnancy remains limited. CDC guidance notes that pregnant women are excluded from World Health Organization ivermectin mass-treatment campaigns and recommends weighing the risks of treatment against the risks posed by the infection.
Ivermectin also passes into human breast milk in low concentrations. Treatment during breastfeeding therefore requires an individual assessment of potential benefits and risks.
Do not self-treat with Ivecop during pregnancy or breastfeeding.
Children weighing less than 15 kg
The safety of ivermectin in children weighing less than 15 kg has not been established in the CDC clinical guidance for strongyloidiasis and scabies.
Because dosing is also usually based on body weight, children should receive ivermectin only when appropriately prescribed.
Loa loa infection
An important but less familiar precaution concerns Loa loa, a filarial parasite occurring mainly in parts of Central and West Africa.
CDC lists confirmed or suspected concomitant Loa loa infection as a relative contraindication when using ivermectin for strongyloidiasis. People with relevant travel or residence history should therefore tell their healthcare professional before treatment.
Other medicines and medical conditions
Tell the prescriber or pharmacist about prescription medicines, non-prescription medicines, and supplements you use before taking ivermectin.
This is particularly important if you have significant medical conditions or are receiving several medicines. Your healthcare professional can assess potential interactions and determine whether ivermectin is suitable for the infection being treated.
How Can Ivecop Be Used Safely?
The safest approach is to use Ivecop for a diagnosed or clinically suspected infection for which ivermectin is appropriate, at the dose and schedule prescribed by a healthcare professional.
Do not assume that a previous prescription can be reused for a new rash or suspected worm infection. Similar symptoms can have very different causes.
If Ivecop is prescribed for scabies, treatment of the medicine alone may not be enough to prevent transmission or reinfestation. CDC advises washing bedding, clothing, and towels in hot water and drying them using high heat; items that cannot be washed can be dry-cleaned or sealed appropriately.
The CDC scabies treatment advice also recommends avoiding direct skin-to-skin contact until treatment is finished and completing treatment as prescribed.
For strongyloidiasis, follow-up may sometimes be necessary. CDC recommends follow-up stool examinations 2–4 weeks after treatment in patients who had positive stool examinations and persistent symptoms.
When Should You Seek Medical Advice?
Talk to a healthcare professional before taking Ivecop if you are pregnant or breastfeeding, are considering treatment for a young child, take multiple medicines, have significant medical conditions, or have lived or travelled in areas where Loa loa infection occurs.
Medical review is also appropriate if symptoms continue after treatment. Persistent itching after scabies treatment, for example, does not automatically mean another ivermectin dose is required, while continuing gastrointestinal symptoms after suspected worm treatment may have another cause.
Seek urgent medical attention if you develop severe difficulty breathing, facial or throat swelling, fainting, severe confusion, a serious skin reaction, or another rapidly worsening reaction after taking the medicine.
Strongyloides infection deserves particular medical attention in people who are immunocompromised or are about to receive high-dose corticosteroids. CDC reports that hyperinfection and disseminated strongyloidiasis can become life-threatening.
Conclusion
Ivecop 12 mg tablets contain ivermectin, an antiparasitic medicine that can be useful against specific infections when appropriately prescribed. However, 12 mg is the tablet strength rather than a universal dose: ivermectin treatment frequently depends on body weight, the parasite involved, and whether repeat treatment is required. Pregnancy, breastfeeding, childhood weight, other medicines, and certain infections can also affect safety.
Use Ivecop only according to medical advice and avoid repeating doses or using it as a general deworming treatment without appropriate assessment. If symptoms persist or worsen after treatment, consult a healthcare professional. This guide provides general medicine information and does not replace your prescription or individualized medical advice.
Frequently Asked Questions
1. What is Ivecop 12 mg used for?
Ivecop 12 mg contains ivermectin, an antiparasitic medicine used against certain parasite infections. Ivermectin has established roles in conditions including strongyloidiasis and may be used for scabies in appropriate circumstances. The exact indication should be confirmed before treatment because ivermectin does not treat every parasite.
2. Is Ivecop 12 mg a deworming tablet?
Ivecop is an antiparasitic medicine, but it should not be considered a universal deworming tablet. Different intestinal worms respond to different medicines and regimens. Appropriate treatment depends on the suspected or confirmed parasite, so routine self-treatment with ivermectin is not recommended.
3. Can I take Ivecop 12 mg for scabies?
Oral ivermectin is an established treatment option for scabies in certain circumstances, although regulatory approval varies by country. CDC guidance uses weight-based dosing and repeat treatment for classic scabies. Use Ivecop for scabies only when a healthcare professional has recommended an appropriate regimen.
4. Is one Ivecop 12 mg tablet enough?
Not necessarily. Ivermectin dosage commonly depends on body weight and the infection being treated, while some conditions require repeat doses. A 12 mg tablet is simply a medication strength, so do not assume that one tablet represents the correct treatment course.
5. What are the common side effects of Ivecop 12 mg?
Reported effects of Ivecop include dizziness, nausea, vomiting, and stomach discomfort. Other symptoms can occur depending on the infection and response to treatment. Seek medical attention for severe allergic symptoms, fainting, significant neurological symptoms, or another serious or rapidly worsening reaction.
6. Can Ivecop 12 mg be taken during pregnancy?
Ivermectin should not be self-administered during pregnancy because human safety data remain limited. CDC notes that treatment decisions should balance the potential risks of the medicine against risks from the infection. Pregnant or breastfeeding patients should discuss ivermectin with a healthcare professional before taking it.vecop 12 mg contains ivermectin, an antiparasitic medicine used against certain parasite infections. Ivermectin has established roles in conditions including strongyloidiasis and may be used for scabies in appropriate circumstances. The exact indication should be confirmed before treatment because ivermectin does not treat every parasite.
Comments